BDBM60217 1,2-dihydroimidazo[1,2-a]benzimidazol-3-yl-(1-piazthiol-4-ylsulfonyl-4-piperidyl)methanone::1-{[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperidin-4-yl]carbonyl}-2,3-dihydro-1H-imidazo[1,2-a]benzimidazole::MLS000091773::SMR000026320::[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-4-piperidinyl]-(1,2-dihydroimidazo[1,2-a]benzimidazol-3-yl)methanone::[1-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperidin-4-yl]-(1,2-dihydroimidazo[1,2-a]benzimidazol-3-yl)methanone::cid_3240530
SMILES O=C(C1CCN(CC1)S(=O)(=O)c1cccc2nsnc12)N1CCn2c1nc1ccccc21
InChI Key InChIKey=GSSFOYNEDBNZSU-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 60217
TargetKappa-type opioid receptor(Human)
Burnham Center For Chemical Genomics
Curated by PubChem BioAssay
Burnham Center For Chemical Genomics
Curated by PubChem BioAssay
Affinity DataIC50: 980nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBMRI, San Diego, C...More data for this Ligand-Target Pair
